The independent source for health policy research, polling, and news.
7,361 - 7,380 of 15,460 Results
The new rules, announced Friday, will significantly expand the number of employers eligible for exemptions from the requirement that they provide women, at no cost, coverage of any contraception method approved by the FDA.
Both President Donald Trump and Sen. Rand Paul (R-Ky.) signaled last week that executive action was in the works that would give these plans a boost.
"If it gets signed by this governor, it's going to send shock waves throughout the country,” one legislator says. Pharma has spent $16.8 million lobbying against this bill and other drug laws in California.
With higher premiums on tap for many Medicare enrollees, here’s help figuring out the particulars of the Part B puzzle and how it affects you.
Medicaid was created in 1965 as a program for the poor. Today, it helps 74 million people — more than 1 of every 5 people in the U.S. You or someone you know likely benefits.
California is one of only a handful of states nationwide that screens babies for the gene mutation that causes a rare brain disease — a test that dramatically increases a sick child’s chances of survival.
In this episode of “What the Health?” Julie Rovner of Kaiser Health News, Stephanie Armour of The Wall Street Journal, Margot Sanger-Katz of The New York Times, and Joanne Kenen of Politico discuss Congress’ tardiness in renewing the Children’s Health Insurance Plan (CHIP), and play the parlor game of who might become the new secretary of Health and Human Services. Also, the pod panel interviews Rep. John Larson (D-Conn.) about his new Medicare buy-in bill.
Hospitals view adding trauma care as a potential profit tool, but experts say having more centers does not necessarily improve the system’s ability to respond to a mass casualty event.
Federal funding for the Children’s Health Insurance Program expired Sept. 30. Many states still have money in their budgets, but they’ll be worried until Congress renews the program.
The drug, sold under the name Mavyret, can cure all six genetic types of the liver disease in eight weeks at a cost of $26,400, well below other options.
Doctors offering this care charge a monthly fee for services that can be handled in the office. But patient advocates warn it is not insurance and offers no coverage for hospital or specialist care.
Technical glitches with a mandatory credentialing course are, many say, the latest in a series of complications that could make it harder to help people get coverage.
Drug companies are in the midst of a glossy publicity campaign to stop attempts to control rising pharma costs. But the devil is in the details.
The inspector general at Health and Human Services says defective pacemakers or defibrillators had to be replaced from 2005 through 2014, costing Medicare $1.5 billion.
Tom Price resigned from running the Department of Health and Human Services after a series of news stories detailing how he tallied more than $400,000 in private plane travel paid for by taxpayers.
Congress has yet to take substantive action on this growing consumer concern, but a number of states are flexing their cost-control muscle.
Research published this week by JAMA Cardiology analyzed pharmacy claims data related to a new class of cholesterol-lowering drugs.
Many women who served in the military decades ago were victims of sexual assaults but often felt compelled to keep quiet.
In this episode of “What the Health?” Julie Rovner of Kaiser Health News, Alice Ollstein of Talking Points Memo, Margot Sanger-Katz of The New York Times and Paige Winfield Cunningham of The Washington Post discuss what happens now that Republicans have officially failed in their latest effort to overhaul Obamacare. Plus an interview with Bruce Lesley of First Focus about the fate of the Children’s Health Insurance Program.
© 2026 KFF